Suppr超能文献

实体器官移植受者多中心队列中的带状疱疹发病率。

Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients.

作者信息

Pergam S A, Forsberg C W, Boeckh M J, Maynard C, Limaye A P, Wald A, Smith N L, Young B A

机构信息

Department of Medicine, University of Washington, Seattle, Washington 98109, USA.

出版信息

Transpl Infect Dis. 2011 Feb;13(1):15-23. doi: 10.1111/j.1399-3062.2010.00547.x.

Abstract

BACKGROUND

Immunosuppressed patients are at increased risk for herpes zoster (HZ), but incidence in solid organ transplant (SOT) recipients has varied in multiple studies. To assess incidence of HZ, we examined patients who underwent SOT and received follow-up care within the large multicenter US Department of Veteran's Affairs healthcare system.

METHODS

Incident cases of HZ were determined using ICD-9 coding from administrative databases. A multivariable Cox proportional hazards model, adjusted for a priori risk factors, was used to assess demographic factors associated with development of HZ.

RESULTS

Among the 1077 eligible SOT recipients, the cohort-specific incidence rate of HZ was 22.2 per 1000 patient-years (95% confidence interval [CI], 18.1-27.4). African Americans (37.6 per 1000 [95% CI, 25.0-56.6]) and heart transplants recipients (40.0 per 1000 [95% CI, 23.2-68.9]) had the highest incidence of HZ. Patients transplanted between 2005 and 2007 had the lowest incidence (15.3 per 1000 [95% CI, 8.2-28.3]). In a multivariable model, African Americans (hazard ratio [HR] 1.88; 95% CI: 1.12, 3.17) and older transplant recipients (HR 1.13; 95% CI: 1.01, 1.27 [per 5-year increment]) had increased relative hazards of HZ.

CONCLUSIONS

These data demonstrate that HZ is a common infectious complication following SOT. Future studies focused on HZ prevention are needed in this high-risk population.

摘要

背景

免疫抑制患者发生带状疱疹(HZ)的风险增加,但在多个研究中,实体器官移植(SOT)受者的发病率有所不同。为评估HZ的发病率,我们在美国退伍军人事务部大型多中心医疗保健系统中检查了接受SOT并接受随访的患者。

方法

使用行政数据库中的ICD-9编码确定HZ的发病病例。采用多变量Cox比例风险模型,并对先验风险因素进行调整,以评估与HZ发生相关的人口统计学因素。

结果

在1077名符合条件的SOT受者中,HZ的队列特异性发病率为每1000患者年22.2例(95%置信区间[CI],18.1 - 27.4)。非裔美国人(每1000例中37.6例[95%CI,25.0 - 56.6])和心脏移植受者(每1000例中40.0例[95%CI,23.2 - 68.9])的HZ发病率最高。2005年至2007年期间接受移植的患者发病率最低(每1000例中15.3例[95%CI,8.2 - 28.3])。在多变量模型中,非裔美国人(风险比[HR]1.88;95%CI:1.12,3.17)和年龄较大的移植受者(HR 1.13;95%CI:1.01,1.27[每增加5岁])发生HZ的相对风险增加。

结论

这些数据表明,HZ是SOT后常见的感染性并发症。需要针对这一高风险人群开展未来聚焦于HZ预防的研究。

相似文献

1
Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients.
Transpl Infect Dis. 2011 Feb;13(1):15-23. doi: 10.1111/j.1399-3062.2010.00547.x.
2
Incidence of herpes zoster in adult solid organ transplant recipients: A meta-analysis and comprehensive review.
Transpl Infect Dis. 2021 Aug;23(4):e13674. doi: 10.1111/tid.13674. Epub 2021 Jul 14.
3
Incidence and risk factors for herpes zoster following heart transplantation.
Transpl Infect Dis. 2014 Feb;16(1):17-25. doi: 10.1111/tid.12149. Epub 2013 Oct 23.
4
Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors.
Front Immunol. 2021 Mar 18;12:645718. doi: 10.3389/fimmu.2021.645718. eCollection 2021.
6
Incidence of herpes zoster in patients with altered immune function.
Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8. Epub 2013 Nov 10.
7
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
JAMA Netw Open. 2023 Apr 3;6(4):e2310687. doi: 10.1001/jamanetworkopen.2023.10687.
8
Incidence and risk factors for herpes zoster in patients undergoing liver transplantation.
Transpl Infect Dis. 2015 Oct;17(5):671-8. doi: 10.1111/tid.12425. Epub 2015 Sep 21.

引用本文的文献

3
Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong.
Hum Vaccin Immunother. 2025 Dec;21(1):2463185. doi: 10.1080/21645515.2025.2463185. Epub 2025 Mar 10.
5
Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
Dig Dis Sci. 2024 Feb;69(2):588-595. doi: 10.1007/s10620-023-08202-x. Epub 2023 Nov 29.
9
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine.
J Gen Intern Med. 2023 Mar;38(4):986-993. doi: 10.1007/s11606-022-07721-z. Epub 2022 Jul 6.
10
Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance.
Ther Adv Vaccines Immunother. 2021 Nov 30;9:25151355211057479. doi: 10.1177/25151355211057479. eCollection 2021.

本文引用的文献

1
Varicella zoster virus (VZV) in solid organ transplant recipients.
Am J Transplant. 2009 Dec;9 Suppl 4(Suppl 4):S108-15. doi: 10.1111/j.1600-6143.2009.02901.x.
5
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis.
Clin Infect Dis. 2009 May 15;48(10):1364-71. doi: 10.1086/598331.
6
Herpes zoster after lung transplantation: incidence, timing, and outcome.
Ann Thorac Surg. 2009 Feb;87(2):423-6. doi: 10.1016/j.athoracsur.2008.11.004.
7
Immunosuppression for liver transplantation.
Gut. 2009 Mar;58(3):452-63. doi: 10.1136/gut.2008.163527. Epub 2008 Dec 3.
8
Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
Clin Transplant. 2008 May-Jun;22(3):263-72. doi: 10.1111/j.1399-0012.2007.00781.x.
9
Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients.
J Am Coll Surg. 2008 May;206(5):1009-16; discussion 1016-8. doi: 10.1016/j.jamcollsurg.2007.12.019. Epub 2008 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验